top of page
Multimodal AI Agent Framework for Integrative Pharmacology and Toxicology Evaluation
Yi Ni*, Liwei Zhu, Shengwei Wang, Chenghao Liu, Debin Zou Bio LIMS INC, a digital intelligence company for life science labs, Massachusetts, United States *Corresponding author: yi.ni@biolims.net AMP 2025 Date — November, 2025 Location — Boston Abstract Traditional pharmacology and toxicology evaluation faces fundamental limits when dealing with massive heterogeneous data, complex biological mechanisms, and individual variability — only 1 in 5,000 to 1 in 10,000 candidate com
Bio LIMS INC
2 min read
Bio AI Agent: A multi-agent artificial intelligence system for autonomous CAR-T cell therapy development with integrated target discovery, toxicity prediction, and rational molecular design
Yi Ni*, Liwei Zhu, Shuai Li Bio LIMS INC, Boston, Massachusetts, United States *Corresponding author: yi.ni@biolims.net arXiv preprint arXiv:2511.08649 November 11, 2025 q-bio.QM · cs.AI Abstract Chimeric antigen receptor T-cell (CAR-T) therapy represents a paradigm shift in cancer treatment, yet development timelines of 8–12 years and clinical attrition rates exceeding 40–60% highlight critical inefficiencies in target selection, safety assessment, and molecular optimization
Bio LIMS INC
2 min read
AI agent applications in digital traceability for cell and gene therapy: COI(Chain of Identity) and coc(Chain of Custody) management
October 15–16, 2025 | Philadelphia, USA The American Society of Gene & Cell Therapy (ASGCT) will host the Advancing Cell + Gene Therapies for Cancer meeting, dedicated to breakthroughs and challenges in oncology-focused CGT. Topics include tumor heterogeneity, viral vector & cell therapy combinations, mechanisms of resistance, gene editing optimization, and cross-platform integration. Bio LIMS INC is proud to share that our work “AI agent applications in digital traceability
Bio LIMS INC
3 min read
BioLIMS 21 CFR Part 11 Compliance White Paper
1. 🔍 Introduction In the era of digital transformation in life sciences , laboratories rely on electronic systems to manage data,...
Bio LIMS INC
4 min read
🚀 BioLIMS Cloud: Ready-to-Use Laboratory Digitalization PlatformTransform your lab from “setup” to “ready” — instantly.
In the fast-moving world of life sciences and pharmaceutical R&D, laboratory digitalization should not take months of complex setup....
Bio LIMS INC
3 min read
BioLIMS — Compliance-First Laboratory Platform
Our Philosophy At BioLIMS Inc. , we believe compliance is not a checkbox — it's a culture. Our platform is purpose-built for regulated...
Bio LIMS INC
3 min read


Bio LIMS INC Debuts at AACR 2025, Building the Intelligent Future of Life-Science Laboratories with Bio-AIAgent
From April 25 to 30, the world’s leading benchmark event in cancer research—the 2025 Annual Meeting of the American Association for Cancer Research (AACR)—was held at Chicago’s McCormick Place. Bio LIMS INC showcased its end-to-end digital laboratory solutions, unveiling a five-pillar product matrix and the LLM-driven Bio-AIAgent intelligence system to demonstrate how AI is infusing new vitality into life-science research. Panoramic Showcase: The Smart Leap from Lab to Commer
Bio LIMS INC
2 min read


AI+Agent+BioLIMS For Life Science Lab
The integration of AI+Agent+BioLIMS into life science laboratories transcends mere functional augmentation; it represents an evolutionary leap from information-based tools to AI-driven intelligent entities. 👍 👍
Bio LIMS INC
1 min read


Bio LIMS INC will be showcased at AACR (American Association for Cancer Research) Annual Meeting 2025. We invite you to visit us at Booth #4304
We are excited to announce that Yi Ni, the Founder and CEO of Bio LIMS INC, will lead the team to participate in AACR2025 (American Association for Cancer Research Annual Meeting). The conference will take place from April 25 to 30, 2025, at the McCormick Place Convention Center in Chicago. Our booth number is 4304, and we warmly invite experts, scholars, and industry partners to join us in exploring the future of cancer research. Bio LIMS INC is a pioneer in the digital tran
Bio LIMS INC
2 min read


Bio LIMS INC actively participated in the J.P. Morgan Week series of events
The annual J.P. Morgan Healthcare Conference has been held in San Francisco, USA, from January 13 to 16, 2025. This is the largest and most influential international healthcare investment and business development conference, attracting top pharmaceutical companies, innovative firms, industry experts, and investors from around the world. Bio LIMS INC, located in Boston and Maryland, focuses on providing comprehensive digital support to life sciences companies, helping them exp
Bio LIMS INC
2 min read


Bio LIMS INC attended AMP 2024 in Vancouver, Canada
On November 23, 2024, the AMP2024 Annual Meeting, hosted by the Association for Molecular Pathology, concluded successfully. This premier event brought together molecular diagnostics experts, researchers, and industry leaders from around the globe to explore cutting-edge advancements and the future of the field. As a pioneer in digital solutions for the industry, Bio LIMS INC actively participated throughout the conference and hosted a highly anticipated Happy Hour side event
Bio LIMS INC
1 min read


Computer System Validation (CSV) Empowering the Life Sciences Industry: A Focus on Bio LIMS INC
In the modern life sciences industry, data integrity, regulatory compliance, and operational efficiency are critical components. Computer...
Bio LIMS INC
3 min read


Bio LIMS INC’s 5M
#1: Man (Personne l) Personnel are the foundation of any successful quality control system. Employees must be properly trained,...
Bio LIMS INC
2 min read


How LLM Can Assist within Bio LIMS INC‘s System
#1 Experimental Knowledge Training Large Language Models can understand and generate complex experimental process instructions, working...
Bio LIMS INC
1 min read


From V1.0 to V10.0, Bio-LIMS® Laboratory Information Management System Development
For precision medicine laboratories, it is far from enough to introduce only one set of information systems. What is more important is...
Bio LIMS INC
2 min read


BIO LIMS Inc's "AI+Digitalization" Strategy
BIO LIMS Inc's "AI + Digitalization" strategy is redefining the paradigm of innovative biopharmaceutical R&D and manufacturing by...
Bio LIMS INC
1 min read
bottom of page
